MAVRIC: A Multicenter Randomized Controlled Trial of Transabdominal vs Transvaginal Cervical Cerclage

Andrew Shennan, Manju Chandiramani, Phillip Bennett, Anna L. David, Joanna Girling, Alexandra Ridout, Paul T. Seed, Nigel Simpson, Steven Thornton, Graham Tydeman, Siobhan Quenby, Jenny Carter

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Abstract

Womenwho experience multiple late miscarriages or spontaneous pretermbirths may be candidates for vaginal cerclage. In women with a history of pregnancy loss with vaginal cerclage, observational studies have suggested that transabdominal cerclage (TAC) may be beneficial over high vaginal cerclage (HVC) and low vaginal cerclage (LVC). However, TAC has not been evaluated in a randomized clinical trial. The aim of this study was to determine if TAC or HVC would result in lower rates of late miscarriage or preterm births compared with LVC in women with a history of pregnancy loss. The Multicentre Abdominal vs Vaginal Randomized Intervention of Cerclage trial was a multicenter randomized clinical trial involving 9 hospitals across the United Kingdom. Women were recruited between January 2008 and September 2014. Eligibility for the study included a history of spontaneous late miscarriage or preterm birth between 14 and 28 weeks of pregnancy with a previous failed cerclage. Women requiring rescue cerclage procedures were excluded.

Original languageEnglish
Pages (from-to)392-394
Number of pages3
JournalObstetrical and Gynecological Survey
Volume75
Issue number7
DOIs
Publication statusPublished - 1 Jul 2020

Fingerprint

Dive into the research topics of 'MAVRIC: A Multicenter Randomized Controlled Trial of Transabdominal vs Transvaginal Cervical Cerclage'. Together they form a unique fingerprint.

Cite this